{"id":"W4385667785","doi":"10.1097/01.hs9.0000969412.43267.61","title":"P627: LONG-TERM OUTCOMES WITH CONTINUOUS IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF TIME TO PROGRESSION","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ibrutinib; Medicine; Internal medicine; Oncology; Progression-free survival; Chronic lymphocytic leukemia; Population; Bruton's tyrosine kinase; Chemotherapy; Leukemia; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002177385,0.0003325282,0.0006976909,0.000684886,0.0003087625,0.0009393982,0.0004410179,0.0005965289,0.0009750889],"category_scores_gemma":[0.002537448,0.0001491618,0.0009000165,0.0008541437,0.0002508991,0.0006599689,0.0006265655,0.0007331595,0.0001947498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005608989,"about_ca_system_score_gemma":0.0004243956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009125164,"about_ca_topic_score_gemma":0.001282911,"domain_scores_codex":[0.9992868,0.0001949557,0.0000804747,0.0001855272,0.0001453457,0.000106832],"domain_scores_gemma":[0.99695,0.0007004634,0.001357856,0.0001869992,0.0002435808,0.0005611938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03451107,0.0004902462,0.9381452,0.0001715662,0.001265597,0.0001645105,0.0001095621,0.0008708704,0.002026786,0.00004540866,0.0005388385,0.02166038],"study_design_scores_gemma":[0.001155116,0.007147563,0.9875579,0.00003382346,0.0007334949,0.0003780879,0.00008185205,0.001377665,0.0005257446,0.00007712076,0.0009126097,0.00001911035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974384,0.001466416,0.00008556026,0.00003908428,0.000005795679,0.00002250721,0.0006101237,0.000005936624,0.0003260651],"genre_scores_gemma":[0.9980726,0.0001746849,0.00007473378,0.00003772846,0.00002794859,0.00003914439,0.001435558,0.000002485329,0.0001350687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002177385,"threshold_uncertainty_score":0.01151526,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0119106456210165,"score_gpt":0.2973486943511449,"score_spread":0.2854380487301284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}